Lumen Gain After Endovascular Therapy in Calcified Superficial Femoral Artery Occlusive Disease Assessed by Intravascular Ultrasound (CODE Study).


Journal

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists
ISSN: 1545-1550
Titre abrégé: J Endovasc Ther
Pays: United States
ID NLM: 100896915

Informations de publication

Date de publication:
06 2019
Historique:
pubmed: 16 3 2019
medline: 9 6 2020
entrez: 16 3 2019
Statut: ppublish

Résumé

To assess calcium patterns in superficial femoral artery (SFA) disease before and after balloon angioplasty ± stent implantation using fluoroscopy, angiography, and intravascular ultrasound (IVUS) imaging and then correlate calcification severity and midterm clinical outcomes. A multicenter investigation was carried out to retrospectively review 130 symptomatic patients (mean age 73.2±8.4 years; 86 men) with de novo SFA lesions who had successfully undergone endovascular therapy (EVT) at 7 centers between January and October 2015. The primary outcome was lumen gain measured as minimum lumen area (MLA) in post-EVT IVUS images according to calcification severity. The secondary outcomes included rates of stent malapposition, restenosis, and clinically-driven target lesion revascularization (TLR). A total of 102 (78.5%) cases had calcification in the lesions over a mean length of 64.3±72.8 mm. Of these, 70 cases were classified as having bilateral calcification according to fluoroscopy and angiography; 50 (49%) lesions had ≥180° calcification according to IVUS. The lumen gain in calcified lesions was significantly smaller than in the 28 noncalcified lesions (14.1±4.4 vs 17.8±5.2 mm IVUS evaluation of calcification in SFA lesions predicted lumen gain after EVT. Severe calcification in a ≥180° arc prevented successful dilation of the lesion with either plain balloon angioplasty or a nitinol stent. Accurate assessment of calcification patterns by IVUS is useful in maximizing the efficacy of endovascular therapy.

Identifiants

pubmed: 30873909
doi: 10.1177/1526602819836095
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

322-330

Commentaires et corrections

Type : CommentIn

Auteurs

Masahiko Fujihara (M)

1 Department of Cardiology, Kishiwada Tokushukai Hospital, Kishiwada, Japan.
2 Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

Amane Kozuki (A)

3 Department of Cardiology, Saiseikai Nakatsu Hospital, Osaka, Japan.

Yoshinori Tsubakimoto (Y)

4 Department of Cardiology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.

Mitsuyoshi Takahara (M)

5 Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Yoshiaki Shintani (Y)

6 Department of Cardiology, Shin-Koga Hospital, Kurume, Japan.

Masashi Fukunaga (M)

7 Department of Cardiology, Morinomiya Hospital, Osaka, Japan.

Yusuke Iwasaki (Y)

8 Department of Cardiology, Osaka General Medical Center, Osaka, Japan.

Tatsuya Nakama (T)

9 Department of Cardiology, Miyazaki Medical Association Hospital, Miyazaki, Japan.

Yoshiaki Yokoi (Y)

1 Department of Cardiology, Kishiwada Tokushukai Hospital, Kishiwada, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH